Pioglitazone: all 341 studies that test it

Page 3 of 4. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.

• Bioavailability of BI 10773 and Pioglitazone in Healthy Male VolunteersCompletedNCT02276365Phase 1
• Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological TreatmentStatus unknownNCT02236962Not applicable
• The Practical Evidence of Antidiabetic Combination Therapy in KoreaCompletedNCT02231021Phase 4
• Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)CompletedNCT02222441Phase 1
• Neuroprotection of Pioglitazone in Acute Ischemic StrokeTerminatedNCT02195791Phase 2
• Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female VolunteersCompletedNCT02183337Phase 1
• Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy VolunteersCompletedNCT02172235Phase 1
• Glycemic Durability After Metformin FailureStatus unknownNCT02142309Phase 4
• A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid TumorsCompletedNCT02133625Phase 1
• Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes PatientsCompletedNCT02027103Not applicable
• Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes PatientsCompletedNCT01963663Not applicable
• Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart DiseaseCompletedNCT01947790Phase 4
• Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 DiabetesCompletedNCT01935804Phase 2
• Triple Therapy in Type 2 Diabetic PatientsStatus unknownNCT01895569Phase 4
• A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male ParticipantsCompletedNCT01873001Phase 1
• Mediators of Abnormal Reproductive Function in Obesity (MARO)CompletedNCT01817400Early Phase 1
• The Impact of Actos Treatment of Diabetes on Glucose Transporters in MuscleCompletedNCT01799850Phase 4
• Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis PatientsWithdrawnNCT01695707Not applicable
• A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322CompletedNCT01686711Phase 4
• Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes PatientsCompletedNCT01593371Not applicable
• Pioglitazone to Treat Opioid Withdrawal SymptomsTerminatedNCT01517165Phase 1
• Effects of Pioglitazone in Hypertensive PatientsCompletedNCT01472497Phase 4
• Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly ParticipantsCompletedNCT01456117Phase 1
• Pioglitazone and Metformin in Diabetic ChildrenCompletedNCT01396564Phase 1/2
• Glucose Control in Pre-Diabetic Renal Transplant PatientsCompletedNCT01346254Phase 2
• The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT)CompletedNCT01331967Phase 4
• Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus ErythematosusCompletedNCT01322308Phase 4
• Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy SubjectsCompletedNCT01309854Phase 1
• Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) PatientsCompletedNCT01258322Not applicable
• Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRDStatus unknownNCT01253928Phase 4
• Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO)CompletedNCT01205282Phase 2
• Endometriosis: ImmunomodulationWithdrawnNCT01184144Phase 2/3
• Thiazolidinedione (TZD) on the Diabetic Retinopathy and NephropathyStatus unknownNCT01175486Phase 4
• Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET ImagingCompletedNCT01174056Early Phase 1
• Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging StudyCompletedNCT01161394Phase 4
• Study the Relationship Between Obesity and Hepatitis C ReplicationWithdrawnNCT01157975Phase 2
• Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain TumorsCompletedNCT01151670Phase 1
• Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 DiabetesTerminatedNCT01124656Phase 3
• Effects of Pioglitazone on Insulin Sensitivity in Healthy Overweight and Obese Males (MK-0000-170)CompletedNCT01115712Phase 1
• Pioglitazone as an Adjunct for Moderate to Severe Depressive DisorderCompletedNCT01109030Phase 2/3
• A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy SubjectsCompletedNCT01088919Phase 1
• Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes MellitusCompletedNCT01082120Phase 1
• The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic SteatohepatitisCompletedNCT01068444Phase 2
• The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus RibavirinStatus unknownNCT01025765Phase 4
• Third-line Therapy of Multiple Myeloma a Prospective Phase I /II TrialStatus unknownNCT01010243Phase 1/2
• Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male SubjectsCompletedNCT01001013Phase 1
• Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 DiabetesStatus unknownNCT00991055Phase 4
• Pioglitazone in Alzheimer DiseaseCompletedNCT00982202Phase 2
• Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) LipoproteinsCompletedNCT00953498Phase 4
• Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin ResistanceTerminatedNCT00927290Phase 3
• Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/RibaCompletedNCT00926614Phase 4
• The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic SyndromeCompletedNCT00926341Phase 4
• Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 SubjectsCompletedNCT00926016Not applicable
• Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00919555Phase 1/2
• Pathophysiology of Uric Acid NephrolithiasisCompletedNCT00904046Not applicable
• Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With GemcitabineTerminatedNCT00867126Early Phase 1
• Safety of Pioglitazone for Hematoma Resolution In Intracerebral HemorrhageCompletedNCT00827892Phase 2
• Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic PatientsCompletedNCT00819325Phase 4
• Molecular Mechanisms of Type 2 Diabetes MellitusCompletedNCT00816218Phase 4
• Pioglitazone Versus Metformin in Type 2 DiabetesCompletedNCT00815399Phase 4
• Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of ConceptCompletedNCT00811681Phase 3
• Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot StudyWithdrawnNCT00775164Phase 4
• Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 DiabetesCompletedNCT00772174Phase 3
• Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.CompletedNCT00771004Phase 2
• Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00770952Phase 3
• Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.CompletedNCT00770835Phase 4
• Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.CompletedNCT00770640Phase 2
• Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular DiseaseCompletedNCT00770575Phase 2
• Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.CompletedNCT00770497Phase 2
• Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.CompletedNCT00770445Phase 4
• Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes MellitusCompletedNCT00762736Phase 2
• Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 DiabetesCompletedNCT00754403Phase 4
• How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?Status unknownNCT00749047Phase 4
• Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease PatientsCompletedNCT00745914Not applicable
• Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis PatientsCompletedNCT00745225Phase 4
• A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.CompletedNCT00744367Phase 3
• Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes MellitusTerminatedNCT00722917Phase 2
• Anti-Inflammatory Effects of PioglitazoneCompletedNCT00722631Not applicable
• Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.CompletedNCT00720577Early Phase 1
• Effect of Pioglitazone on Inflammation in Cystic FibrosisCompletedNCT00719381Phase 1
• Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)CompletedNCT00694759Not applicable
• Study of Pioglitazone in Patients With Amyotrophic Lateral SclerosisTerminatedNCT00690118Phase 2
• Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH)Status unknownNCT00681733Not applicable
• Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With InsulinCompletedNCT00676260Phase 2
• Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.CompletedNCT00672919Phase 4
• Pioglitazone Incretin StudyCompletedNCT00656864Phase 4
• Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mgCompletedNCT00649558Phase 1
• Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mgCompletedNCT00649012Phase 1
• Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver DiseaseCompletedNCT00633282Phase 2
• Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 DiabetesCompletedNCT00609856Phase 4
• Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat AsthmaWithdrawnNCT00604578Phase 2
• Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without DiabetesCompletedNCT00598013Not applicable
• Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With InsulinCompletedNCT00576784Phase 4
• Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced CirrhosisCompletedNCT00570622Phase 4
• Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes MellitusCompletedNCT00545857Phase 1
• Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart FailureTerminatedNCT00521820Phase 3
• Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac DiseaseCompletedNCT00521742Phase 3
• Influence of Pioglitazone for Renal Transplant Function in DiabeticsCompletedNCT00507494Phase 3
• The Effect of Pioglitazone on Neointima Volume and Inflammatory MarkersCompletedNCT00494559Phase 4
• Safety Study of Pioglitazone Compared To Glyburide on Liver FunctionCompletedNCT00494312Phase 4

← Pioglitazone overview